An FDA committee said one type of nasal decongestant doesn’t work, but experts say here’s what does Thursday, September 28 by ABC News(NEW YORK) -- Over-the-counter agents to treat upper respiratory symptoms like nasal congestion make up a multi-billion-dollar business. But recently, a Food and Drug Administration advisory committee ruled that oral phenylephrine, commonly found in some over-the-counter, or OTC, products like Dayquil, Mucinex, and Sudafed... Read More.
FDA approves Pfizer’s new nasal spray treatment for migraines Friday, March 10 by ABC News(WASHINGTON) -- The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) -- the first and only migraine treatment of its kind to be offered in nasal spray.The drug has shown in clinical trial data to provide... Read More.